Working… Menu

A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01656018
Recruitment Status : Completed
First Posted : August 2, 2012
Last Update Posted : April 7, 2016
Information provided by (Responsible Party):
Janssen Research & Development, LLC